Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care cung cấp cho các bạn kiến thức về ngành y đề tài: Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. | Available online http content 10 3 R97 Research Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia Andrew F Shorr1 Ying P Tabak2 Vikas Gupta2 RS Johannes2 Larry Z Liu3 and Marin H Kollef4 Pulmonary and Critical Care Medicine Service Washington Hospital Center Washington District of Columbia USA 2Cardinal Health Clinical - Research Group 500 Nickerson Road Marlborough Massachusetts USA 3Pfizer Inc New York New York USA 4Washington University School of Medicine St. Louis Missouri USA Corresponding author Andrew F Shorr afshorr@ Received 16 Feb 2006 Revisions requested 22 Mar 2006 Revisions received 20 Apr 2006 Accepted 3 May 2006 Published 29 Jun 2006 Critical Care 2006 10 R97 doi cc4934 This article is online at http content 10 3 R97 2006 Shorr et al. licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Open Access Abstract Introduction To gain a better understanding of the clinical and economic outcomes associated with methicillin-resistant Staphylococcus aureus MRSA infection in patients with early onset ventilator-associated pneumonia VAP we retrospectively analyzed a multihospital US database to identify patients with VAP over a 24 month period 2002-2003 . Method Data recorded included physiologic laboratory culture and other clinical variables from 59 institutions. VAP was defined as new positive respiratory culture after at least 24 hours of mechanical ventilation MV and the presence of primary or secondary ICD-9-CM diagnosis codes of pneumonia. Outcomes measures included in-hospital morbidity and mortality for the population overall and after onset of VAP duration of MV intensive care unit ICU stay in-hospital .
